WEPOG
ABMD

Wealth Enhancement & Preservation of GA’s Abiomed Inc ABMD Stock Holding History

Wealth Enhancement & Preservation of GA’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,731
Closed -$1.04M – 64
2020
Q3 		$1.04M Buy
+3,731
New +$1.07M 1.07% 20

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wealth Enhancement & Preservation of GA's ABMD Position: Q4 2020 in Review

Wealth Enhancement & Preservation of GA sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 3,731 shares — an estimated $1.04M sold.

Wealth Enhancement & Preservation of GA first reported a position in ABMD in Q3 2020 and held it in 1 quarter. The position peaked at $1.04M in Q3 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Wealth Enhancement & Preservation of GA reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Wealth Enhancement & Preservation of GA sold 3,731 Abiomed Inc shares in Q4 2020, an estimated $1.04M.
  • Wealth Enhancement & Preservation of GA first reported a position in Abiomed Inc in Q3 2020 and held it in 1 quarter.
  • Wealth Enhancement & Preservation of GA's Abiomed Inc position peaked at $1.04M in Q3 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Wealth Enhancement & Preservation of GA's 13F filing for Q4 2020, filed 2 Feb 2021.